RECURSION PHARMACEUTICALS, INC. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Recursion Pharmaceuticals, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Recursion Pharmaceuticals, Inc. Assets for the quarter ending September 30, 2024 was $726M, a 15.2% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$726M	+$95.7M	+15.2%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$776M	+$109M	+16.4%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$558M	-$69.5M	-11.1%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$654M	-$47.6M	-6.79%	Dec 31, 2023	10-Q	2024-11-06
Q3 2023	$631M	+$19.3M	+3.16%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$667M	-$5.82M	-0.87%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$627M	-$107M	-14.6%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$701M	+$90.9M	+14.9%	Dec 31, 2022	10-K	2024-02-29
Q3 2022	$612M	-$47.1M	-7.15%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$673M	-$26.1M	-3.73%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$734M	+$462M	+170%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$610M	+$312M	+104%	Dec 31, 2021	10-K	2023-02-27
Q3 2021	$659M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$699M			Jun 30, 2021	10-Q	2021-08-13
Q1 2021	$272M			Mar 31, 2021	10-Q	2021-05-12
Q4 2020	$299M			Dec 31, 2020	10-K	2022-03-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.